BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
3061 – 3070 of 3086
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1.
- Contribution to journal › Article
-
Mark
MicroRNAs and other small silencing RNAs in cancer.
- Contribution to journal › Article
-
Mark
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
- Contribution to journal › Article
-
Mark
PCA3 as a diagnostic marker for prostate cancer: A validation study on a Swedish patient population.
- Contribution to journal › Article
-
Mark
Delays in the management of retroperitoneal sarcomas.
- Contribution to journal › Article
-
Mark
Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome Wide Expression Data: A Validation Study.
- Contribution to journal › Article
-
Mark
Intraductal papillary mucinous neoplasms of the pancreas: diagnosis and management.
- Contribution to journal › Article
-
Mark
Male infertility and prostate cancer risk: a nested case-control study.
- Contribution to journal › Article
-
Mark
Genetic bottlenecks and the hazardous game of population reduction in cell line based research.
- Contribution to journal › Article
-
Mark
Ubiquitin chain cleavage: CYLD at work.
- Contribution to journal › Article
